1. Japan Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Sugi Holdings Co., Ltd.

Sugi Holdings Co., Ltd.

6.85
EUR
-0.10
(-1.44%)
0.42EPS
Jan 08Next Earn
Sugi Holdings Co., Ltd.
HAM:UGI
(Hamburg Stock Exchange)

Recent

price

6.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
802.12
861.45
904.48
961.32
1,009.87
1,092.12
1,134.01
1,203.12
1,305.72
1,461.28
1,625.45
1,686.46
1,844.78
2,057.06
2,426.02
5,582.88
- -
Revenue per Share
23.69
30.08
33.25
33.75
33.86
38.45
39.35
43.2
47.96
56.03
56.95
52.28
52.52
60.73
70.98
248.56
- -
Basic EPS, GAAP
37.84
35.19
13.33
26.51
64.4
7.87
13.23
41.7
12.87
67.31
33.61
-43.69
46.33
17.52
30.13
337.25
- -
Free Cash Flow per Basic Share
1.99
2.5
4.99
5.16
7.33
6.67
8.33
8.33
11.71
12.49
13.33
13.33
13.57
13.33
14.17
34.97
- -
Dividend per Share
217.83
245.33
273.62
302.21
327.15
360.06
391.65
426.57
449.09
492.74
540.95
576.7
598.34
644.79
692.68
802.49
- -
Book Value per Share
211.67
239.17
267.82
296.63
318.78
352.04
383.11
418.76
441.01
483.19
526.59
558.87
575.9
616.18
548.71
660.09
- -
Tangible Book Value per Share
380
380
380
380
380
380
380
380
374
371
371
371
362
362
362
181
362
Basic Weighted Avg Shares
304,730
327,267
343,613
365,200
383,644
414,885
430,795
457,047
488,464
541,964
602,850
625,477
667,647
744,477
878,021
1,010,336
- -
Sales/Revenue/Turnover
12.81
5.26
5.36
5.51
5.44
5.57
5.3
5.42
5.29
5.49
5.65
5.14
4.74
4.92
4.85
4.81
- -
Operating Margin (%)
3,742
3,934
4,787
4,994
4,952
5,267
5,599
6,455
7,389
8,412
9,940
11,268
12,362
14,179
17,871
20,110
- -
Depreciation Expense
8,999
11,426
12,630
12,820
12,862
14,605
14,947
16,411
17,940
20,782
21,120
19,389
19,007
21,979
25,689
44,982
- -
Net Income, GAAP
35.03
41.09
42.79
39.49
38.42
36.02
33.63
33.17
31.14
30.56
32.99
29.38
32.56
31.53
32.53
0.43
- -
Effective Tax Rate (%)
2.95
3.49
3.68
3.51
3.35
3.52
3.47
3.59
3.67
3.83
3.5
3.1
2.85
2.95
2.93
4.45
- -
Profit Margin (%)
38,856
48,789
56,802
65,613
73,655
80,959
86,717
94,049
83,938
81,104
85,480
89,869
82,969
62,398
30,400
79,442
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
521
2,064
67,193
- -
LT Debt
82,755
93,203
103,947
114,808
124,281
136,783
148,781
162,046
166,562
182,748
200,629
213,888
216,537
233,361
250,704
290,473
- -
Total Equity
10.19
11.11
10.34
10.8
10.41
10.97
10.39
10.42
10.53
11.52
11.54
10.74
9.77
10.83
10.53
13.97
- -
Return on Invested Capital (%)
11.45
13
12.82
11.73
10.77
11.2
10.48
10.57
10.93
11.91
11.03
9.36
8.84
9.76
9.75
13.48
- -
Return on Capital (%)
11.44
12.99
12.81
11.72
10.76
11.19
10.47
10.56
10.92
11.9
11.02
9.35
8.83
9.77
10.61
16.62
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
May'25
Aug'25
May'27
ST Debt
10,816
10,771
- -
LT Borrowings
439
406
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
362
362
362
Market Capitalization
- -
- -
- -

Working Capital

JPY

•

in mil. unless spec.
May'25
Aug'25
May'27
Total Current Assets
207,732
244,528
- -
Cash, Cash Equivalents & STI
48,732
78,181
- -
Accounts Receivable, Net
48,815
51,795
- -
Inventories
86,414
83,514
- -
Total Current Liabilities
150,890
181,649
- -
Payables & Accruals
- -
- -
- -
ST Debt
10,816
10,771
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.89%
7.78%
15.86%
Free Cash Flow
61.8%
7.2%
459.68%
Net Income, GAAP
13.64%
19.49%
75.1%
Sales/Revenue/Turnover
9.4%
11%
15.07%
Total Cash Common Dividend
- -
- -
23.44%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
200,959
212,850
- -
- -
878,021
2026
- -
- -
- -
- -
1,010,336
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
16.92
19.16
- -
- -
70.98
2026
- -
- -
- -
- -
248.56
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
14.17
2026
- -
- -
- -
- -
34.97
2027
- -
- -
- -
- -
- -
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Sugi Holdings Co., Ltd. is a Japan-based holding company that primarily engages in the operation of drugstores and dispensing pharmacies through its subsidiaries, offering prescription and generic drugs, over-the-counter medicines, health supplements, cosmetics, health and beauty goods, groceries, daily necessities, pet supplies, and health foods; it also provides self-care support services including meal delivery, cancer and health checkups, specific health guidance, disease prevention programs, home-visit nursing, shopping and mobility assistance, online medication instruction, and comprehensive community care in cooperation with regional medical institutions. The company operates over 2,100 stores primarily in the Kanto, Chubu, Kansai, and Hokuriku-Shinshu regions of Japan, with additional international activities in Asia through S Trading, including partnerships for product supply and expansion in countries such as Taiwan, Vietnam, Malaysia, Thailand, Hong Kong, Indonesia, and the Philippines. Founded in December 1976 and headquartered in Obu-City, Aichi, Japan, Sugi Holdings employs 11,820 people on a consolidated basis and reported net sales of 878.021 billion yen for the fiscal year ended February 2025. Recent developments include the August 2025 acquisition of a 34.8% stake in Seki Yakuhin Co., Ltd., a Saitama-based drugstore operator with over 300 stores, positioning it as an equity method affiliate with plans to increase ownership to 49% by September 2025 and to 51% within five years for full consolidation; strategic partnerships such as with PT Mustika Ratu Tbk in 2024 for halal cosmetics and drugs, and with AC Health in the Philippines in 2025 to distribute products across 800 outlets; and ongoing expansion of its Total Healthcare Strategy integrating digital tools like the SUGI Pharmacy App for personalized health management.